About 20% of bladder cancers have truncating and inactivating mutations in the AT-rich interactive domain 1A (ARID1A) gene, a member of the SWI/SNF chromatin modifying complex, making it one of the most frequently mutated epigenetic genes in bladder cancer. This evidence concerns the gene ARID1A and urinary bladder carcinoma.